Pharmaceutical industry Trusts

Racial/ethnic group membership was expected to be an important factor in an individual s level of trust of these institutions. Controlling for gender, age, education, and income, African Americans were about 40% less likely than whites to trust universities Asians and Hispanics were nearly twice as likely as whites to trust the federal government. However, race/ethnicity was not a factor in trust in the pharmaceutical industry nor in trust in health organizations. 

In the pharmaceutical industry, chromatographic QC methods are often used with no changes over long time frames. The basic reason for this is the amount of effort necessary for a complete revalidation of a method on a new column brand. Because of these constraints, chromatographic columns should be chosen from reliable and reputable manufacturers that can sustain a reproducible production of the columns over such extended time periods. Until recently, the capability of column manufacturers to reproduce the packing materials was not known, and users needed to rely on their intuition and trust the column manufacturers. 

CLINICAL TRIAL AGREEMENT EOR PHARMACEUTICAL INDUSTRY SPONSORED RESEARCH IN NHS TRUSTS... 

In short, the success of the modern pharmaceutical industry is firmly built on the remarkable achievements of organic synthesis over the last century. However, the down side is that many of these time-honored and trusted synthetic methodologies were developed in an era when the toxic properties of many reagents and... 

But the pharmaceutical industry isn t like any other industry. By virtue of what it produces—and the respect it demands for what it produces—it does carry some social service obligations. The public expects drug makers to be more ethical than the proverbial widget makers prescription drug commercials prompt public outrage in a way that McDonald s ads do not. If the industry is ever to gain the public s trust, more companies will have to behave like the old Merck. In fact, Merck will have to behave like the old Merck. 

The current public view of modern medicines, ably fuelled by the mass media, is a compound of vague expectation of miracle cures with outrage when anything goes wrong. It is also unreasonable to expect the public to trust the medical profession (in collaboration with the pharmaceutical industry) to the extent of leaving to them all drug matters. 

The FDA s reputation for fairness and impartiality was dented in 1989 by scandal, corruption, and fraud. The pharmaceutical industry, particularly that part concerned with the manufacture of generic products, was also tainted. The FDA s backlash has been to move away from systems of trust toward strict enforcement of compliance. The linchpin of the FDA s new attitude has been preapproval inspection, incorporated into formal enforcement programs on October 1, 1990. 

THE SWISS PHARMACEUTICAL INDUSTRY THE IMPACT OF INDUSTRIAL PROPERTY RIGHTS AND TRUST IN THE LABORATORY, 1907-1939... 

We have never got an expert who we can trust to go there [pharmaceutical industry] and do an evaluation and I said to them then I should become a banker. (Technical expert, Kenyan pharmaceutical sector, 2014)... 

---